anti tumor natural product library

A unique collection of 1812 natural products with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 517 flavonoids can be used for high throughput and high content screening；

A unique collection of 1544 metabolism diseases related compounds for high throughput screening (HTS) and high content screening (HCS);

A collection of 382 TCM monomers with anti-colorectal activity. An effective tool for drug development and pharmacological studies.

A unique collection of 1268 cancer cellular metabolism related compounds for cancer research and high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1702 compounds with anti-lung cancer therapeutic activity or targeting lung cancer’s major signaling pathways, can be used for anti-lung cancer drug discovery and mechanism study；

A unique collection of 3580 compounds with known anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1147 monomers from 60 TCM plants, a powerful tool for anti-COVID-19 drug discovery, can be used for HTS and HCS screening；

A unique collection of 1213 anti-virus compounds effective for new anti-virus drugs high throughput screening and high content screening;

A unique collection of 1180 potential anti-fibrosis compounds, can be used in HTS and HCS;

A unique collection of 595 saccharides and glycosides compounds can be used for HTS and HCS；

A unique collection of 2154 compounds related to neurodegenerative diseases can be used for HTS or HCS；

A unique collection of 500 natural alkaloids can be used for high throughput and high content screening；

A unique collection of 2247 anti-obesity compounds for high throughput and high content screening;

A unique collection of 4533 pure natural products and their derivatives with known biological activity for drug discovery, pharmacological study, stem cell differentiation, fingerprint study and quality research, and can be used for high throughput screen

A unique collection of 904 antibacterial bioactive compounds, a powerful tool for antibacterial drug development;

A unique collection of 7234 compounds with anti-cancer activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 683 diabetes related compounds;

A unique collection of 685 microbial natural products for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 390 antifungal compounds effective for drug repurposing screening, combination screening and biological investigation.

A unique collection of 144 marine natural products for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1408 cardiovascular diseases related compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 3840 natural products for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 800 natural polyphenolic compounds for high throughput screening (HTS) and high content screening (HCS);

Well-chosen 1246 compounds with unique structures targeting nervous system;

A unique collection of 1074 species of natural products with anti-infective activity for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 2703 natural product monomers that meet the Lipinski's Rule of Five , a powerful tool for HTS and HCS screening;

A unique collection of 1779 approved anti-cancer drugs for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 1133 compounds with confirmed anti-SARS-CoV-2 activity or potential activity and part of them are broad-spectrum antiviral agents；

A unique collection of 2938 anti-infective compounds including anti-bacterial, anti-fungi, anti-Human Cytomegalovirus (HCMV), anti-HIV, anti-SARS, anti-influenza, etc;

A unique collection of 4880 anti-aging compounds for high throughput screening (HTS) and high content screening (HCS);

A unique collection of 16627 pure natural products with diverse structures and sources covering various plant, animal, and microbe species;

530 non-steroidal anti-inflammatory compounds for high-throughput and high-content screening.

A unique collection of 693 rare natural products, which can be used for high throughput screening (HTS) and high content screening (HCS);

A collection of 288 TCM monomers with anti-virus activity. An effective tool for drug development and pharmacological studies.

A unique collection of 622 natural terpenes and terpenoids can be used for high throughput and high content screening；

419 well-chosen unique anti-parasitic small molecules;

1787 species of compounds related to liver cancer that can be used in anti-liver cancer drug development and pharmacological studies.

A unique collection of 1939 compounds with anti-breast cancer therapeutic activity or targeting breast cancer’s major signaling pathways, can be used for anti-breast cancer drug discovery and mechanism study；

A unique collection of 1867 compounds with anti-ovarian cancer therapeutic activity, can be used for anti-ovarian cancer drug discovery and pharmacological study;

1545 compounds associated with colorectal cancer that can be used for high-throughput and high-content screening.

Well-chosen 1468 anti-tumor compounds with unique structures;

Detialed biological information and pharmacological information of the products, providing theoretical direction and research basis for screening.

The library consists of more than 4,000 members belonging 22 scaffolds (average 180 compounds per scaffold).

2070 compounds associated with prostate cancer that can be used for high-throughput and high-content screening.

A unique collection of 2051 natural products included in Chinese Pharmacopoeia (CP), a powerful tool for drug development and pharmacological study;

A unique collection of 2238 pancreatic cancer related compounds can be used in HTS and HCS;

A collection of 1279 TCM monomers with anti-inflammatory activity or targeting molecular therapeutic targets in inflammation, a powerful tool for drug discovery and mechanism study；